A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors

NCT04073680 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Endometrial Cancer
Lung Cancer
Colo-rectal Cancer
Head and Neck Cancer

Interventions

DRUG: Serabelisib
DRUG: Canagliflozin 300mg

Sponsor

Petra Pharma